March 2, 2017 / 12:28 PM / 5 months ago

BRIEF-22nd Century Group gets FDA guidance meeting for X-22 smoking cessation aid

1 Min Read

March 2 (Reuters) - 22nd Century Group Inc

* Granted FDA guidance meeting for X-22 smoking cessation aid

* Says intends to seek "fast track" designation by fda for x-22

* Says will seek agreement from CDER/FDA on appropriate path for x-22 to become a prescription-based cessation aid for smokers in U.S Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below